Skip to main content
رجوع
ACHC logo

Acadia Healthcare Company, Inc.

جودة البيانات: 100%
ACHC
NASDAQ Healthcare Medical - Care Facilities
KWD 24.31
▲ KWD 1.62 (7.14%)
القيمة السوقية: 2.24B
نطاق اليوم
KWD 22.59 KWD 24.32
نطاق 52 أسبوعًا
KWD 11.43 KWD 31.04
حجم التداول
2,909,271
متوسط 50 يوم / 200 يوم
KWD 17.68 / KWD 19.87
الإغلاق السابق
KWD 22.69

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -2.0 0.2
P/B 1.2 3.0
ROE % -43.9 3.6
Net Margin % -33.3 3.8
Rev Growth 5Y % 9.4 9.7
D/E 1.4 0.2

السعر المستهدف للمحللين

Hold
KWD 19.82 -18.5%
Low: KWD 14.00 High: KWD 25.00
مكرر الربحية المستقبلي
15.00
ربحية السهم المستقبلية
KWD 1.51
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.41B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 1.83
KWD 1.80 – KWD 1.87
 4.20B 1
FY2028 KWD 1.88
KWD 1.84 – KWD 1.92
 3.82B 2
FY2027 KWD 1.72
KWD 1.61 – KWD 1.96
 3.61B 7

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-25 KWD 0.01 KWD 0.07 +683.0%
2025-11-05 KWD 0.68 KWD 0.72 +5.9%
2025-08-05 KWD 0.71 KWD 0.83 +16.9%
2025-05-12 KWD 0.35 KWD 0.40 +14.3%
2025-02-27 KWD 0.75 KWD 0.64 -14.7%
2024-10-30 KWD 0.90 KWD 0.91 +1.1%
2024-07-31 KWD 0.87 KWD 0.91 +4.6%
2024-05-01 KWD 0.81 KWD 0.84 +3.7%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 9.38% annually over 5 years — modest growth
Earnings declined -531.42% over the past year
Negative free cash flow of -439.91M
PEG of 0.00 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.34%

النمو

Revenue Growth (5Y)
9.38%
Revenue (1Y)5.04%
Earnings (1Y)-531.42%
FCF Growth (3Y)N/A

الجودة

Return on Equity
-43.91%
ROIC6.32%
Net Margin-33.29%
Op. Margin11.71%

الأمان

Debt / Equity
1.36
Current Ratio1.55
Interest Coverage2.79

التقييم

P/E Ratio
-2.03
Forward P/E15.00
P/B Ratio1.15
EV/EBITDA12.28
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.04% Revenue Growth (3Y) 6.35%
Earnings Growth (1Y) -531.42% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 9.38% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.31B Net Income (TTM) -1.10B
ROE -43.91% ROA -19.95%
Gross Margin 17.61% Operating Margin 11.71%
Net Margin -33.29% Free Cash Flow (TTM) -439.91M
ROIC 6.32% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.36 Current Ratio 1.55
Interest Coverage 2.79
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.03 Forward P/E 15.00
P/B Ratio 1.15 P/S Ratio 0.68
PEG Ratio 0.00 Forward PEG N/A
EV/EBITDA 12.28 Fwd EV/EBITDA 15.57
Forward P/S 0.66 Fwd Earnings Yield 6.67%
FCF Yield -19.62%
Market Cap 2.24B Enterprise Value 4.76B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.31B 3.15B 2.93B 2.61B 2.31B
Net Income -1.10B 255.61M -21.67M 273.14M 190.64M
EPS (Diluted) -12.16 2.78 -0.24 2.98 2.10
Gross Profit 583.44M 711.98M 682.61M 2.51B 2.22B
Operating Income 387.97M 522.28M 506.60M 467.70M 414.47M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.53B 5.96B 5.36B 4.99B 4.77B
Total Liabilities 3.39B 2.77B 2.47B 2.09B 2.19B
Shareholders' Equity 1.95B 3.07B 2.78B 2.81B 2.52B
Total Debt 2.65B 2.09B 1.51B 1.53B 1.64B
Cash & Equivalents 133.24M 76.31M 100.07M 97.65M 133.81M
Current Assets 814.14M 577.49M 596.00M 506.13M 495.03M
Current Liabilities 525.19M 577.92M 885.78M 388.33M 404.86M